Abstract
Key Points Hypertrophic cardiomyopathy is the most common genetic cardiac disease. Reverse cardiac remodeling after alcohol septal ablation has been reported in patients with obstructive hypertrophic cardiomyopathy who are symptomatic despite medical therapy. No data exist on early percutaneous therapy to reverse adverse remodeling and improve prognosis in asymptomatic patients with severe left ventricular outflow tract obstruction.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
